2255-19-8Relevant academic research and scientific papers
Butyrylcholinesterase Inhibitors
-
Paragraph 0104; 0105; 0112, (2016/08/17)
Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated
A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis
Spivak, David A.,Hoffman, Timothy Z.,Moore, Alisa H.,Taylor, Matthew J.,Janda, Kim D.
, p. 1145 - 1150 (2007/10/03)
A new amine-oxide hapten was employed as an antigen, producing seven monoclonal antibodies (mAbs) from a panel of 20 that catalyzed paraoxon hydrolysis. The current hapten design differs from that previously described in that the molecule is inherently mo
